OTC · Drug Manufacturers - Specialty & Generic

Cannara Biotech Inc. (LOVFF) Stock

$1.33 -3.47% OTC: LOVFF Healthcare

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations.

Valuation

MetricValue
Price$1.33
Market Cap$131.11M
P/E Ratio17.22
P/B Ratio1.46
P/S Ratio1.56
EPS (TTM)$0.08
52-Week High$1.47
52-Week Low$1.11
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE9.45%
ROA5.58%
ROCE0.07%
Gross Margin26.30%
Operating Margin0.10%
Net Margin9.22%
Debt/Equity0.29
Current Ratio3.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$17.0M$36.0M$57.0M$82.0M$107.0M
Operating Profit$0$5.0M$12.0M$10.0M$22.0M
Net Profit$-2.0M$2.0M$7.0M$6.0M$13.0M
EPS$-0.02$0.03$0.08$0.07$0.14
Op Margin1.5%13.8%20.8%12.3%20.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$92.0M$126.0M$142.0M$155.0M$169.0M
Total Liabilities$28.0M$59.0M$62.0M$67.0M$66.0M
Cash$8.0M$12.0M$4.0M$7.0M$14.0M
Borrowings$21.0M$48.0M$46.0M$48.0M$42.0M

Latest News

Cannara Biotech to Begin a Normal Course Issuer Bid MT Newswires · Jul 22, 2026 Cannara Announces Normal Course Issuer Bid GlobeNewswire · Jul 22, 2026 Cannara Biotech Price Target Raised to C$4 at TD MT Newswires · Jul 16, 2026 Cannara Biotech Inc (LOVFF) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and ... GuruFocus.com · Jul 15, 2026 Cannara Biotech Fiscal Q3 Earnings, Revenue Rise MT Newswires · Jul 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$-6.0M$6.0M$11.0M$20.0M
Investing Cash Flow$-62.0M$-31.0M$-19.0M$-13.0M$-12.0M
Financing Cash Flow$-1.0M$-2.0M$-2.0M$-4.0M$-4.0M
Net Cash Flow$0$4.0M$-8.0M$2.0M$8.0M
Free Cash Flow$-33.0M$-22.0M$-4.0M$3.0M$14.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.49
EV / EBITDA14.21
FCF Yield2.58%
Quick Ratio1.29
Interest Coverage0.04
Return 1Y-0.95%
Return 3Y70.53%
Return 5Y—

Ownership

Insiders Held50.10%
Institutions Held0.25%
Institutions Float Held0.50%
Institutional HolderSharesReport Date
AdvisorShares Investments, LLC247,8942026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BIOYFBioSyent Inc. $10.50 +0.41% 18.10 $120.04M 1.52%
CBWTFAuxly Cannabis Group Inc. $1.87 +0.54% 7.58 $191.48M 0.00%
GRUSFGrown Rogue International Inc. $0.41 +2.68% -123.21 $102.47M 0.00%
HLTRFHLS Therapeutics Inc. $2.98 +0.00% -9.24 $93.20M 0.00%
KNTPFKintor Pharmaceutical Limited $0.23 -0.20% -3.33 $107.85M 0.00%

About Cannara Biotech Inc.

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivative products in Canada. The company operates in two segment Cannabis operations and Real estate operations. It offers its products under TRIBAL, nugz, and ORCHID CBD brand name. The company sells its products through wholesalers and online merchandisers. In addition, it engages in the real estate operations. Cannara Biotech Inc. was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.

Cannara Biotech Inc. is headquartered in CA.

Cannara Biotech Inc. (LOVFF) stock trades at $1.33 with a market capitalization of $131.11M. The stock is valued at a price-to-earnings (P/E) ratio of 17.22, price-to-book of 1.46, price-to-sales of 1.56. Over the past 52 weeks the stock has ranged between $1.11 and $1.47, and currently trades 9.5% below its 52-week high.

On profitability, Cannara Biotech Inc. generates a return on equity (ROE) of 9.45%, return on capital employed of 0.07%, an operating margin of 0.10%, a net profit margin of 9.22%.

Official website: cannara.ca

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides